BEOVU
Live / Registered — Registered — Section 71 accepted (as of 17 Dec 2024)
What this means for you
Registered since 19 Jun 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 Jun 2028: the §71 ten-year affidavit of use).
Record
- Serial number
- 79226907
- Registration number
- 5494796
- Mark type
- Word mark
- Filed
- 06 Nov 2017
- Published for opposition
- 03 Apr 2018
- Registered
- 19 Jun 2018
- Next maintenance filing
- §71 ten-year affidavit of use, due by 19 Jun 2028 (grace period to 19 Dec 2028)
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: [ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; ] pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; [ pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; ] pharmaceutical preparations for ophthalmological use [ ; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]
Owner
- NOVARTIS AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, Basel, CH
Prosecution history
- 16 Apr 2026 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 10 Feb 2026 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 10 Feb 2026 — INVALIDATION PROCESSED
- 17 Aug 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 17 Dec 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 17 Dec 2024 — REGISTERED-SEC.71 ACCEPTED
- 13 Nov 2024 — TEAS SECTION 15 RECEIVED
- 13 Nov 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Mar 2024 — TEAS SECTION 71 RECEIVED
- 03 Aug 2018 — NOTIFICATION PROCESSED BY IB
- 19 Jul 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 19 Jul 2018 — FINAL DISPOSITION PROCESSED
- 19 Jul 2018 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 19 Jun 2018 — REGISTERED-PRINCIPAL REGISTER
- 03 Apr 2018 — PUBLISHED FOR OPPOSITION